J.P. Morgan Maintains Overweight Rating on IMAX Corporation
J.P. Morgan has reaffirmed its 'Overweight' rating for IMAX Corporation, maintaining a positive outlook on the company's stock.
Stocks · News reference
Morgan Stanley Initiates Coverage On Imax with Overweight Rating, Announces Price Target of $63
Morgan Stanley analyst Daniel Duran initiates coverage on Imax (NYSE:IMAX) with a Overweight rating and announces Price Target of $63.
Reference Details
Connected Markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- benzinga
- Observed
- Checked
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related Headlines
Wells Fargo Maintains Equal-Weight on Imax, Raises Price Target to $55
Wedbush Maintains Outperform on Imax, Raises Price Target to $60
Wedbush analyst Alicia Reese maintains Imax (NYSE:IMAX) with a Outperform and raises the price target from $54 to $60.
New Strong Buy Stocks for October 12th
Five stocks have been added to the Zacks Rank #1 (Strong Buy) list, driven by increasing earnings estimates over the last 60 days. The stocks span energy, manufacturing, entertainment, insurance, and retail sectors, with earnings estimate increases ranging from 10% to 15.4%. The market is focused on upcoming CPI and PPI inflation reports and the start of Q3 earnings season.